Castle Biosciences
CSTL
CSTL
188 hedge funds and large institutions have $1.41B invested in Castle Biosciences in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 80 increasing their positions, 55 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.43% more ownership
Funds ownership: 83.01% → 85.43% (+2.4%)
6% less capital invested
Capital invested by funds: $1.51B → $1.41B (-$97.9M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
188
Holding in Top 10
1
Calls
$2.19M
Puts
$767K
Top Buyers
| 1 | +$26.8M | |
| 2 | +$11.9M | |
| 3 | +$11.3M | |
| 4 |
CA
CastleArk Alternatives
Chicago,
Illinois
|
+$9.83M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.86M |
Top Sellers
| 1 | -$31.1M | |
| 2 | -$13.3M | |
| 3 | -$7.12M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$7.09M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
-$4.77M |